[HTML][HTML] A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera, B Seoane… - BMC Pulmonary …, 2014 - Springer
Background Long-acting β 2-adrenergic agonists (LABAs) are recommended in combination
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera, B Seoane… - BMC pulmonary …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Long-acting β2-adrenergic agonists (LABAs) are recommended in combination
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
D Singh, H Pujol, A Ribera, B Seoane… - BMC Pulmonary …, 2014 - search.ebscohost.com
Background Long-acting β< sub> 2-adrenergic agonists (LABAs) are recommended in
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
[PDF][PDF] A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera, B Seoane, E Massana… - 2014 - core.ac.uk
Abstract Background: Long-acting β2-adrenergic agonists (LABAs) are recommended in
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting? 2-adrenergic agonist, in asthma; a Phase II, randomized study.
D Singh, H Pujol, A Ribera, B Seoane… - 1471 …, 2014 - escholar.manchester.ac.uk
BACKGROUND: Long-acting β2-adrenergic agonists (LABAs) are recommended in
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
[HTML][HTML] A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera… - BMC …, 2014 - bmcpulmmed.biomedcentral.com
Long-acting β2-adrenergic agonists (LABAs) are recommended in combination with inhaled
corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective, potent, once …
corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective, potent, once …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting [beta] 2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera, B Seoane… - BMC Pulmonary …, 2014 - go.gale.com
Background Long-acting [beta]. sub. 2-adrenergic agonists (LABAs) are recommended in
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
D Singh, H Pujol, A Ribera… - BMC Pulmonary …, 2014 - research.manchester.ac.uk
BACKGROUND: Long-acting β2-adrenergic agonists (LABAs) are recommended in
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
combination with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a …
[HTML][HTML] A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
D Singh, H Pujol, A Ribera, B Seoane… - BMC Pulmonary …, 2014 - ncbi.nlm.nih.gov
Background Long-acting β 2-adrenergic agonists (LABAs) are recommended in combination
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
D Singh, H Pujol, A Ribera, B Seoane… - BMC Pulmonary …, 2014 - europepmc.org
Background Long-acting β2-adrenergic agonists (LABAs) are recommended in combination
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …
with inhaled corticosteroids (ICSs) for asthma management. Abediterol is a novel, selective …